Evidence map›Paper›PMID 33857158›Full record

ArticlePloS one2021

D-(+)-Galactose-induced aging: A novel experimental model of erectile dysfunction.

Mathania Silva de Almeida Rezende, Arthur José Pontes Oliveira de Almeida, Tays Amanda Felisberto Gonçalves, Fátima de Lourdes Assunção Araújo de Azevedo, Sabine Helena Dantas, Sonaly de Lima Silva, Evyllen Myllena Cardoso Soares, Hayaly Felinto Alves, Thais Trajano Lima, Javanyr Frederico de Souza Júnior and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Inflammation and aging: signaling pathways and intervention therapies.Signal transduction and targeted therapy · 2023
    Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Mathania Silva de Almeida RezendePrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Arthur José Pontes Oliveira de AlmeidaPrograma de Pós-graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.ORCID 0000-0003-2501-3249
Tays Amanda Felisberto GonçalvesPrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Fátima de Lourdes Assunção Araújo de AzevedoPrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Sabine Helena DantasPrograma de Mestrado Profissional em Gerontologia, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.ORCID 0000-0001-8724-3029
Sonaly de Lima SilvaPrograma de Pós-graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.ORCID 0000-0003-4888-1188
Evyllen Myllena Cardoso SoaresCentro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Hayaly Felinto AlvesCentro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Thais Trajano LimaCentro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Javanyr Frederico de Souza JúniorCentro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.ORCID 0000-0003-0029-3352
Ricardo Romão GuerraDepartamento de Ciências Veterinárias, Centro de Ciências Agrárias, Universidade Federal da Paraíba, Areia, Paraíba, Brazil.
Islania Giselia Albuquerque AraújoPrograma de Mestrado Profissional em Gerontologia, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
Isac Almeida de MedeirosPrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.ORCID 0000-0001-8783-4806
Universidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erectile dysfunction (ED) is defined as the inability to achieve and/or maintain penile erection sufficient for satisfactory sexual relations, and aging is one of the main risk factors involved. The D-(+)-Galactose aging model is a consolidated methodology for studies of cardiovascular aging; however, its potential for use with ED remain unexplored. The present study proposed to characterize a new experimental model for ED, using the D-(+)-Galactose aging model. For the experiments, the animals were randomly divided into three groups receiving: vehicle (CTL), D-galactose 150 mg/kg (DGAL), and D-(+)-galactose 150 mg/Kg + sildenafil 1.5 mg/Kg (DGAL+SD1.5) being administered daily for a period of eight weeks. All of the experimental protocols were previously approved by the Ethics Committee on the Use of Animals at the Federal University of Paraíba n° 9706070319. During the treatment, we analyzed physical, molecular, and physiological aspects related to the aging process and implicated in the development of ED. Our findings demonstrate for the first time that D-(+)-Galactose-induced aging represents a suitable experimental model for ED assessment. This was evidenced by an observed hyper-contractility in corpora cavernosa, significant endothelial dysfunction, increased ROS levels, an increase in cavernous tissue senescence, and the loss of essential penile erectile components.

Indexed as

AgingAnimalsDisease Models, AnimalElectric StimulationErectile DysfunctionGalactoseMalePenile ErectionPenisRatsRats, WistarReactive Oxygen SpeciesSildenafil CitrateGalactoseReactive Oxygen SpeciesSildenafil Citrate

Identifiers

PMID33857158
PMCPMC8049229
OpenAlexW3156085437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.